{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:18:06Z","timestamp":1783178286314,"version":"3.54.6"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22XD1403200"],"award-info":[{"award-number":["22XD1403200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["2021-01-07-00-10-E00116"],"award-info":[{"award-number":["2021-01-07-00-10-E00116"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["2023-01-07-00-10-E00046"],"award-info":[{"award-number":["2023-01-07-00-10-E00046"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574435"],"award-info":[{"award-number":["82574435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204430"],"award-info":[{"award-number":["82204430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874319"],"award-info":[{"award-number":["81874319"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.phrs.2026.108214","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:10:19Z","timestamp":1777579819000},"page":"108214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Orlistat targets NEDD8 conjugating enzyme UBC12 for cancer therapy"],"prefix":"10.1016","volume":"228","author":[{"given":"Mengzhen","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piliang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xisong","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.phrs.2026.108214_bib1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41576-024-00699-w","article-title":"The origin and evolution of Wnt signalling","volume":"25","author":"Holzem","year":"2024","journal-title":"Nat. Rev. Genet."},{"issue":"10","key":"10.1016\/j.phrs.2026.108214_bib2","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1158\/2159-8290.CD-21-0190","article-title":"WNT as a driver and dependency in cancer","volume":"11","author":"Parsons","year":"2021","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.phrs.2026.108214_bib3","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1158\/2159-8290.CD-21-0190","article-title":"WNT as a driver and dependency in cancer","volume":"11","author":"Parsons","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.phrs.2026.108214_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"33","key":"10.1016\/j.phrs.2026.108214_bib5","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1073\/pnas.1604520113","article-title":"Axitinib blocks Wnt\/beta-catenin signaling and directs asymmetric cell division in cancer","volume":"113","author":"Qu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11 3","key":"10.1016\/j.phrs.2026.108214_bib6","first-page":"35","article-title":"Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase","author":"Hogan","year":"1987","journal-title":"Int. J. Obes."},{"issue":"3","key":"10.1016\/j.phrs.2026.108214_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0005-2760(88)90260-3","article-title":"Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin","volume":"962","author":"Borgstr M","year":"1988","journal-title":"Biochim. Et. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.phrs.2026.108214_bib8","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20204203","article-title":"Effects of orlistat combined with enzalutamide and castration through inhibition of fatty acid synthase in a PC3 tumor-bearing mouse model","volume":"41","author":"Tyan","year":"2021","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2026.108214_bib9","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/0008-5472.CAN-06-1794","article-title":"Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells","volume":"67","author":"Little","year":"2007","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.phrs.2026.108214_bib10","first-page":"1483","article-title":"The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells","volume":"40","author":"Fujiwara","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"29","key":"10.1016\/j.phrs.2026.108214_bib11","doi-asserted-by":"crossref","first-page":"30540","DOI":"10.1074\/jbc.M405061200","article-title":"A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2","volume":"279","author":"Knowles","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108214_bib12","first-page":"33","article-title":"RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells","volume":"15","author":"Menendez","year":"2005","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108214_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/ijgc-00009577-200601000-00035","article-title":"The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2\/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin) in chemoresistant ovarian cancer cells","volume":"16","author":"Menendez","year":"2006","journal-title":"Int. J. Gynecological Cancer Off. J. Int. Gynecological Cancer Soc."},{"issue":"2","key":"10.1016\/j.phrs.2026.108214_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/ijo.2012.1465","article-title":"Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat","volume":"41","author":"Huang","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108214_bib15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.biopha.2011.02.016","article-title":"Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal","volume":"65","author":"Chuang","year":"2011","journal-title":"Biomed. Pharmacother Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.phrs.2026.108214_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102128","article-title":"Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma","volume":"24","author":"Ruiz-P\u00e9rez","year":"2021","journal-title":"iScience"},{"issue":"11","key":"10.1016\/j.phrs.2026.108214_bib17","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/ijc.23835","article-title":"Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model","volume":"123","author":"Carvalho","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2026.108214_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/13543784.2018.1471132","article-title":"Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy","volume":"27","author":"Schcolnik-Cabrera","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"6","key":"10.1016\/j.phrs.2026.108214_bib19","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/0008-5472.CAN-03-3645","article-title":"Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity","volume":"64","author":"Kridel","year":"2004","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.phrs.2026.108214_bib20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/ja907716f","article-title":"Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities","volume":"132","author":"Yang","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"15_","key":"10.1016\/j.phrs.2026.108214_bib21","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/JCO.2016.34.15_suppl.2512","article-title":"Preliminary activity in the first in human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640","volume":"34","author":"Dean","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108214_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114918","article-title":"Orlistat delays hepatocarcinogenesis in mice with hepatic co-activation of AKT and c-Met","volume":"392","author":"Zhang","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108214_bib23","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20204203","article-title":"Effects of orlistat combined with enzalutamide and castration through inhibition of fatty acid synthase in a PC3 tumor-bearing mouse model","volume":"41","author":"Tyan","year":"2021","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2026.108214_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/ja907716f","article-title":"Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities","volume":"132","author":"Yang","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"20","key":"10.1016\/j.phrs.2026.108214_bib25","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1242\/dev.128.20.3877","article-title":"Ectopic Wnt signal determines the eyeless phenotype of zebrafish masterblind mutant","volume":"128","author":"van de Water","year":"2001","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.phrs.2026.108214_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/9780470559277.ch110180","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"3","author":"Lomenick","year":"2011","journal-title":"Curr. Protoc. Chem. Biol."},{"issue":"20","key":"10.1016\/j.phrs.2026.108214_bib27","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1111\/febs.17222","article-title":"TRAF2 associates with cullin neddylation complex assembly","volume":"291","author":"Wang","year":"2024","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.phrs.2026.108214_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110319","article-title":"Liquidambaric acid inhibits Wnt\/\u03b2-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2","volume":"38","author":"Yan","year":"2022","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.phrs.2026.108214_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neo.2020.02.003","article-title":"Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes","volume":"22","author":"Yu","year":"2020","journal-title":"Neoplasia (N. Y. N. Y. )"},{"issue":"2","key":"10.1016\/j.phrs.2026.108214_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009370","article-title":"Lentiviral vectors to probe and manipulate the Wnt signaling pathway","volume":"5","author":"Fuerer","year":"2010","journal-title":"PloS One"},{"issue":"33","key":"10.1016\/j.phrs.2026.108214_bib31","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1073\/pnas.1604520113","article-title":"Axitinib blocks Wnt\/\u03b2-catenin signaling and directs asymmetric cell division in cancer","volume":"113","author":"Qu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"34","key":"10.1016\/j.phrs.2026.108214_bib32","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.1073\/pnas.0404875101","article-title":"A small molecule inhibitor of beta-catenin\/CREB-binding protein transcription [corrected]","volume":"101","author":"Emami","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2026.108214_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm979","article-title":"Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor","volume":"10","author":"Sato","year":"2004","journal-title":"Nat. Med."},{"issue":"20","key":"10.1016\/j.phrs.2026.108214_bib34","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1242\/dev.128.20.3877","article-title":"Ectopic Wnt signal determines the eyeless phenotype of zebrafish masterblind mutant","volume":"128","author":"van de Water","year":"2001","journal-title":"Development (Cambridge England)"},{"issue":"1","key":"10.1016\/j.phrs.2026.108214_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2005.05.026","article-title":"Early stages of zebrafish eye formation require the coordinated activity of Wnt11, Fz5, and the Wnt\/beta-catenin pathway","volume":"47","author":"Cavodeassi","year":"2005","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.phrs.2026.108214_bib36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.gendis.2023.02.050","article-title":"WNT\/\u03b2-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities","volume":"11","author":"Gajos-Michniewicz","year":"2023","journal-title":"Genes Dis."},{"issue":"2","key":"10.1016\/j.phrs.2026.108214_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cmet.2014.05.022","article-title":"Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal","volume":"20","author":"Sounni","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2026.108214_bib38","article-title":"Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer","volume":"13","author":"Xu","year":"2023","journal-title":"Front. Oncol."},{"issue":"3-4","key":"10.1016\/j.phrs.2026.108214_bib39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00249-021-01509-5","article-title":"Isothermal titration calorimetry (ITC): a standard operating procedure (SOP)","volume":"50","author":"Bastos","year":"2021","journal-title":"Eur. Biophys. J. EBJ"},{"issue":"9","key":"10.1016\/j.phrs.2026.108214_bib40","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.phrs.2026.108214_bib41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.molcel.2009.01.011","article-title":"E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification","volume":"33","author":"Huang","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2026.108214_bib42","article-title":"Pevonedistat suppresses pancreatic cancer growth via inactivation of the neddylation pathway","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108214_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.str.2012.10.013","article-title":"Structural conservation of distinctive N-terminal acetylation-dependent interactions across a family of mammalian NEDD8 ligation enzymes","volume":"21","author":"Monda","year":"2013","journal-title":"Struct. (Lond. Engl. 1993)"},{"issue":"19","key":"10.1016\/j.phrs.2026.108214_bib44","first-page":"4283","article-title":"Clinical significance of SCCRO (DCUN1D1) in prostate cancer and its proliferation-inhibiting effect on Lncap cells","volume":"21","author":"Zhang","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108214_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-021-01070-w","article-title":"Targeting neddylation E2s: a novel therapeutic strategy in cancer","volume":"14","author":"Zheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phrs.2026.108214_bib46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/msb.2009.72","article-title":"Application of an integrated physical and functional screening approach to identify inhibitors of the Wnt pathway","volume":"5","author":"Miller","year":"2009","journal-title":"Mol. Syst. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108214_bib47","first-page":"S12","article-title":"Mode of action of orlistat. International journal of obesity and related metabolic disorders","volume":"21","author":"Guerciolini","year":"1997","journal-title":"J. Int. Assoc. Study Obes."},{"issue":"8","key":"10.1016\/j.phrs.2026.108214_bib48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nsmb1265","article-title":"Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat","volume":"14","author":"Pemble","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108214_bib49","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/0008-5472.CAN-06-1794","article-title":"Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells","volume":"67","author":"Little","year":"2007","journal-title":"Cancer Res."},{"issue":"29","key":"10.1016\/j.phrs.2026.108214_bib50","doi-asserted-by":"crossref","first-page":"30540","DOI":"10.1074\/jbc.M405061200","article-title":"A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2","volume":"279","author":"Knowles","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"46","key":"10.1016\/j.phrs.2026.108214_bib51","doi-asserted-by":"crossref","first-page":"31378","DOI":"10.1074\/jbc.M803384200","article-title":"Inhibition of fatty-acid synthase induces caspase-8-mediated tumor cell apoptosis by up-regulating DDIT4","volume":"283","author":"Knowles","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108214_bib52","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24325","article-title":"SENP8 limits aberrant neddylation of NEDD8 pathway components to promote cullin-RING ubiquitin ligase function","volume":"6","author":"Coleman","year":"2017","journal-title":"eLife"},{"issue":"11","key":"10.1016\/j.phrs.2026.108214_bib53","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1080\/15548627.2019.1596484","article-title":"Suppression of autophagy during mitosis via CUL4-RING ubiquitin ligases-mediated WIPI2 polyubiquitination and proteasomal degradation","volume":"15","author":"Lu","year":"2019","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.phrs.2026.108214_bib54","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.18632\/aging.102749","article-title":"UBE2M promotes cell proliferation via the \u03b2-catenin\/cyclin D1 signaling in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.phrs.2026.108214_bib55","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/nar\/gku1384","article-title":"Neddylation inhibits CtIP-mediated resection and regulates DNA double strand break repair pathway choice","volume":"43","author":"Jimeno","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.phrs.2026.108214_bib56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10565-019-09503-6","article-title":"Effective targeting of the ubiquitin-like modifier NEDD8 for lung adenocarcinoma treatment","volume":"36","author":"Jiang","year":"2020","journal-title":"Cell Biol. Toxicol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108214_bib57","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/cas.13865","article-title":"Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer","volume":"110","author":"Tian","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phrs.2026.108214_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115732","article-title":"Micafungin: a promising inhibitor of UBE2M in cancer cell growth suppression","volume":"260","author":"Mamun","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:41:07Z","timestamp":1783176067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826001295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":58,"alternative-id":["S1043661826001295"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108214","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orlistat targets NEDD8 conjugating enzyme UBC12 for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108214"}}